Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (381-390 of 715) with videos related to

Pageof 72
Sort By:
FEBS Letters|August 19, 1999
Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator geneP Merchiers, F Bulens, A De Vriese, et al.
Thrombosis and Haemostasis|December 27, 1982
Kinetics of the inhibition of plasmin in acidified human plasmaH R Lijnen, M Maes, M Castel, et al.
Methods in Enzymology|January 1, 1993
Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. IntroductionK B Reid, K F Nolan, H R Lijnen, et al.
Blood|May 15, 1989
The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitroH R Lijnen, B Van Hoef, F De Cock, et al.
Thrombosis Et Diathesis Haemorrhagica|April 30, 1972
Fibrinogen metabolism in healthy dogs and in dogs with CCl 4 -induced liver damage and with portal vein occlusionG N Tytgat, D Collen, L S Oei, et al.
Thrombosis and Haemostasis|August 13, 1990
Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PAH R Lijnen, B Van Hoef, F De Cock, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.
Journal of Cardiovascular Pharmacology|April 1, 1988
Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosisP Cambier, F van de Werf, G R Larsen, et al.
The Journal of Biological Chemistry|October 25, 1988
Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activatorL Hansen, Y Blue, K Barone, et al.
European Journal of Biochemistry|January 1, 1982
Messenger RNA for human tissue plasminogen activatorG Opdenakker, H Weening, D Collen, et al.
Pageof 72

Showing results (381-390 of 715) with videos related to

Sort By:
Pageof 72
FEBS Letters|August 19, 1999
Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator geneP Merchiers, F Bulens, A De Vriese, et al.
Thrombosis and Haemostasis|December 27, 1982
Kinetics of the inhibition of plasmin in acidified human plasmaH R Lijnen, M Maes, M Castel, et al.
Methods in Enzymology|January 1, 1993
Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. IntroductionK B Reid, K F Nolan, H R Lijnen, et al.
Blood|May 15, 1989
The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitroH R Lijnen, B Van Hoef, F De Cock, et al.
Thrombosis Et Diathesis Haemorrhagica|April 30, 1972
Fibrinogen metabolism in healthy dogs and in dogs with CCl 4 -induced liver damage and with portal vein occlusionG N Tytgat, D Collen, L S Oei, et al.
Thrombosis and Haemostasis|August 13, 1990
Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PAH R Lijnen, B Van Hoef, F De Cock, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.
Journal of Cardiovascular Pharmacology|April 1, 1988
Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosisP Cambier, F van de Werf, G R Larsen, et al.
The Journal of Biological Chemistry|October 25, 1988
Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activatorL Hansen, Y Blue, K Barone, et al.
European Journal of Biochemistry|January 1, 1982
Messenger RNA for human tissue plasminogen activatorG Opdenakker, H Weening, D Collen, et al.
Pageof 72